Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esmolol vs Remifentanil in Intracranial Surgery
NCT01628562Phase 4Completed
- Sponsor
- Dışkapı Yıldırım Beyazıt Training and Research Hospital
- Start
- Jun 2012
- Primary completion
- Sep 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of esmolol in tachycardia, hypertension (HTN), Myocardial ischemia (MI), sponsored by Dışkapı Yıldırım Beyazıt Training and Research Hospital. Started Jun 2012; status: completed.
02
Drugs
esmolol
03
Conditions
tachycardiahypertension (HTN)Myocardial ischemia (MI)
Beyond the preview
Go deeper on NCT01628562.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01628562.